PACS Group Reports Strong Q1 Results, Significantly Raises 2026 EBITDA Guidance, and Authorizes $250M Share Buyback
PACS has more than doubled off its 52-week low of $7.5.
Summary
PACS Group announced strong Q1 2026 financial results, including significant increases in revenue and net income, leading to a substantial raise in its full-year Adjusted EBITDA guidance and the authorization of a $250 million share repurchase program.
Key Events · Earnings and Guidance · PACS
-
Strong First Quarter Financial Performance
PACS Group reported Q1 2026 revenue of $1.42 billion, an 11.2% increase year-over-year. Net income surged by 184.2% to $80.7 million, and Adjusted EBITDA grew by 74.6% to $170.4 million, partly boosted by $16.3 million from California's WQIP.
-
Significant Increase in 2026 Adjusted EBITDA Guidance
The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $605 million to $625 million, up from the prior range of $555 million to $575 million. This represents approximately 22% growth over 2025 at the midpoint.
-
Reaffirmed Revenue Guidance with Stronger Organic Growth
PACS Group reaffirmed its 2026 revenue guidance of $5.65 billion to $5.75 billion, notably excluding contributions from future acquisitions that were previously assumed to add $120 million. This implies stronger organic revenue performance than initially anticipated.
-
New $250 Million Share Repurchase Authorization
The Board of Directors approved a new share repurchase authorization of $250 million, effective May 7, 2026. This program allows for opportunistic repurchases in the open market or privately negotiated transactions.
Analysis · PACS · Industrial Applications And Services
This filing is highly important as PACS Group delivered robust first-quarter financial results, significantly exceeding prior-year performance across key metrics like revenue, net income, and Adjusted EBITDA. The company's decision to raise its full-year 2026 Adjusted EBITDA guidance by approximately 9% at the midpoint, while reaffirming revenue guidance despite excluding future acquisitions, signals strong underlying organic growth and operational confidence. Furthermore, the approval of a substantial $250 million share repurchase authorization provides management with a flexible tool to return capital to shareholders, indicating a positive outlook on the company's valuation and future cash flow generation.
At the time of this filing, PACS was trading at $37.98 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5B. The 52-week trading range was $7.50 to $43.08. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.